Geode Capital Management, LLC Clearside Biomedical, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 790,373 shares of CLSD stock, worth $324,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
790,373
Previous 792,247
0.24%
Holding current value
$324,052
Previous $728,000
13.19%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CLSD
# of Institutions
49Shares Held
11.9MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA3.36MShares$1.38 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$900,9663.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$618,4200.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$327,2360.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny555KShares$227,3490.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $24.7M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...